TWD 24.2
(-0.21%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 499.69 Million TWD | -11.03% |
2022 | 561.65 Million TWD | -5.46% |
2021 | 594.1 Million TWD | -4.88% |
2020 | 624.59 Million TWD | -6.75% |
2019 | 669.82 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 456.6 Million TWD | 0.0% |
2024 Q1 | 472.5 Million TWD | -5.01% |
2023 Q3 | 499.69 Million TWD | -5.38% |
2023 FY | 499.69 Million TWD | -11.03% |
2023 Q1 | 528.12 Million TWD | -5.97% |
2023 Q2 | 528.12 Million TWD | 0.0% |
2023 Q4 | 499.69 Million TWD | 0.0% |
2022 Q3 | 561.65 Million TWD | 0.0% |
2022 Q4 | 561.65 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | -593.79% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | -556.207% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | -51.217% |
TTY Biopharm Company Limited | 403.04 Million TWD | -23.979% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 65.744% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 77.317% |
Center Laboratories, Inc. | 4.42 Billion TWD | 88.718% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -132445.093% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | -54.354% |
InnoPharmax Inc. | 5.38 Million TWD | -9177.664% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | -395.577% |
Excelsior Biopharma Inc. | 300.25 Million TWD | -66.426% |
DV Biomed Co., Ltd. | 315.74 Million TWD | -58.257% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -3710.103% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -6414.079% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -361997.826% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -791.405% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -1099.23% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | -661.092% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |